Back to top
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com Most Recent Articles
Pinterest Rides on Solid ARPU Growth: Will the Uptrend Continue?
Analyst Blog
by Aritra Chatterjee
PINS' rising ARPU across regions and expanding Gen Z user base spotlight its momentum as AI-driven personalization lifts engagement.
SNAPNegative Net Change PINSNegative Net Change RDDTPositive Net Change
artificial-intelligence communications tech-stocks
Company News for Nov 20, 2025
Corporate Summary
by Zacks Equity Research
Companies in The News Are: DLB,LOW,TJX,DY
DLBPositive Net Change TJXPositive Net Change LOWPositive Net Change DYPositive Net Change
construction consumer-discretionary retail
Can SiTime (SITM) Climb 28.17% to Reach the Level Wall Street Analysts Expect?
Tale of the Tape
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 28.2% in SiTime (SITM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
SITMPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
NCLH Hits $1B in Quarterly EBITDA: Peak Performance or Just the Start?
Analyst Blog
by Zacks Equity Research
Norwegian tops $1 billion in quarterly EBITDA as record demand, higher yields and soaring bookings fuel confidence in its profit expansion path.
CCLPositive Net Change RCLPositive Net Change NCLHNegative Net Change
consumer-discretionary
MRK HIV Regimen Meets Goal in New Study, Gains EU Nod for Keytruda SC
Analyst Blog
by Zacks Equity Research
Merck reports strong new HIV study results showing non-inferiority of DOR/ISL to Gilead's Biktarvy and secures an EU approval for its faster-to-administer SC version of Keytruda.
MRKNegative Net Change GILDPositive Net Change ADMAPositive Net Change ARQTPositive Net Change
biotechnology biotechs medical oncology-screening pharmaceuticals
Should You Buy, Sell or Hold Zscaler Stock Before Q1 Earnings?
Analyst Blog
by Subham Roy
ZS eyes Q1 revenue and EPS targets as demand for its security platforms grows, even as tight budgets and longer deal cycles add pressure.
PANWNegative Net Change CYBRNegative Net Change ZSNegative Net Change CRWDPositive Net Change
cybersecurity
CVS Aetna's New Generative AI Assistant Aims to Simplify Health Care
Analyst Blog
by Moumi Mondal
CVS Health's Aetna debuts an embedded generative AI assistant designed to simplify benefits navigation and elevate the consumer health experience.
CAHPositive Net Change CVSNegative Net Change CNCNegative Net Change
medical medical-devices
NIKE vs Steven Madden: How Two Footwear Leaders Stack Up for Investors
Analyst Blog
by Rajani Lohia
NKE and SHOO reveal contrasting strategies, demand trends and valuations as investors weigh stability against momentum.
NKEPositive Net Change SHOONo Net Change
apparel consumer-discretionary
Will RGTI's Tech Roadmap and Strong Cash Position Fuel Momentum Ahead?
Analyst Blog
by Harshit Gupta
Rigetti secures new Novera orders, a key Air Force contract, and a solid cash cushion as it advances its ambitious quantum roadmap.
QUBTNegative Net Change RGTINegative Net Change QBTSPositive Net Change
computers internet
Hershey's LesserEvil Buyout to Strengthen Better-for-You Snacks
Analyst Blog
by Zacks Equity Research
HSY expands better-for-you lineup with the completed LesserEvil acquisition, boosting its reach in clean-label, fast-growing salty snacks.
HSYNegative Net Change UNFINegative Net Change CHEFPositive Net Change LWNegative Net Change
consumer-staples
Reasons to Add HealthEquity Stock to Your Portfolio for Now
Analyst Blog
by Zacks Equity Research
HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q2 results, though data security threats remain a key risk.
BSXNegative Net Change ISRGPositive Net Change HQYPositive Net Change MEDPPositive Net Change
medical medical-devices
Shell Signs PPAs for Renewable Power to Fuel REFHYNE 2 Project
Analyst Blog
by Zacks Equity Research
SHEL secures major wind and solar PPAs in Germany to power its REFHYNE 2 electrolyzer and advance large-scale green hydrogen production.
OIIPositive Net Change CNQNegative Net Change USACPositive Net Change SHELNegative Net Change
energy oil-energy
Is Primoris Positioned to Gain From Rising Power and Network Demand?
Analyst Blog
by Amit Kr Ram
PRIM rides surging data-center demand as power delivery, communications and EPC network projects fuel strong growth momentum.
PWRPositive Net Change STRLPositive Net Change PRIMPositive Net Change
construction
Will Comfort Systems' Growing Technology Exposure Support an Edge?
Analyst Blog
by Amit Kr Ram
FIX's expanding technology work, record backlog and strong data-center demand highlight its growing momentum and long-term opportunity.
PWRPositive Net Change EMENegative Net Change FIXPositive Net Change
construction
SCVL Q3 Earnings & Sales Meet Estimates, Comparable Sales Dip Y/Y
Analyst Blog
by Zacks Equity Research
Shoe Carnival's third-quarter EPS and sales meet estimates, but comparable store sales slip as rebanner investments weigh on results.
AEONegative Net Change BOOTPositive Net Change SCVLPositive Net Change SHOONo Net Change
earnings retail
REGN Gets EC Nod for Libtayo Label Expansion, FDA Clears Monthly Eylea HD
Analyst Blog
by Zacks Equity Research
Regeneron gains EC approval to expand Libtayo's use in high-risk CSCC. The FDA approves Eylea HD the treatment of patients with macular edema following retinal vein occlusion.
REGNNegative Net Change SNYNegative Net Change RHHBYNegative Net Change BAYRYNegative Net Change
biotechnology biotechs medical pharmaceuticals
Gold Fields' Q3 Production Jumps 22% on Strong Salares Norte Ramp-Up
Analyst Blog
by Zacks Equity Research
GFI's 22% production surge, fueled by Salares Norte's ramp-up and steadier output elsewhere, underscores rising operational momentum.
AUPositive Net Change GFIPositive Net Change DRDPositive Net Change
basic-materials
Blue Owl Backs Off: Market Conditions Send the Merger Flying South
Analyst Blog
by Kaibalya Pravo Dey
OBDC drops its planned merger with OBDC II as market conditions sour, raising investor concerns and prompting a reassessment of strategic options.
ARCCPositive Net Change BXSLPositive Net Change OBDCPositive Net Change
finance
What Role Do Global Partnerships Play in Advancing Boeing's Strategy?
Analyst Blog
by Tanvi Sarawagi
BA taps global partners to expand market reach, boost innovation and strengthen performance across key divisions.
BANegative Net Change EADSYNegative Net Change EMBJPositive Net Change
aerospace
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal
Analyst Blog
by Zacks Equity Research
DexCom receives FDA clearance for DexCom Smart Basal titration software module, which optimizes basal insulin dose in type 2 diabetes patients by integrating with the G7 15 day sensor.
MASINegative Net Change DXCMNegative Net Change GMEDPositive Net Change MEDPPositive Net Change
medical medical-devices
ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal
Analyst Blog
by Zacks Equity Research
Alkermes lifts its bid to buy Avadel for $22.50 per share as its takeover fight with Lundbeck intensifies and shifts the deal's momentum.
ALKSNegative Net Change CRMDNegative Net Change AVDLPositive Net Change CSTLPositive Net Change
biotechs
Kohl's Q3 Earnings Coming Up: Factors Investors Need to Understand
Analyst Blog
by Zacks Equity Research
KSS' third-quarter results are likely to reflect soft traffic, pressured consumers and rising cost and pricing headwinds despite steadier proprietary brand trends.
KSSNegative Net Change DGNegative Net Change ULTANegative Net Change FIVEPositive Net Change
retail
Can ONDS' Acquisition Spree Accelerate Its Multi-Domain Strategy?
Analyst Blog
by Vaishali Doshi
Ondas accelerates its multi-domain push with rapid acquisitions spanning robotics, optics, subsurface intelligence and counter-UAS tech.
ONDSNegative Net Change DPROPositive Net Change UMACNegative Net Change
tech-stocks
Will OKLO's Siemens Agreement Strengthen Its Long-Term Story?
Analyst Blog
by Nilanjan Choudhury
OKLO jumps as its binding Siemens Energy deal pushes the Aurora project into construction and cuts major supply-chain risk.
LBRTPositive Net Change VRTPositive Net Change OKLOPositive Net Change
alt-energy artificial-intelligence energy oil-energy
Best Income Stocks to Buy for Nov. 20th
Zacks #1 Rank Additions
by Zacks Equity Research
SHIP, PAHC and FCFS made it to the Zacks Rank #1 (Strong Buy) income stocks list on November 20, 2025.
FCFSPositive Net Change PAHCNegative Net Change SHIPNegative Net Change
business-services medical transportation
Canadian National Stock Falls 2.5% Since Q3 Earnings Release
Analyst Blog
by Zacks Equity Research
CNI posts a Q3 beat on earnings and revenues, but the stock slips as cost cuts, stronger volumes and a better operating ratio shape a mixed reaction.
DALNegative Net Change CNINegative Net Change JBHTNegative Net Change
transportation
Archer vs. Joby: Which eVTOL Stock Should You Buy Right Now?
Analyst Blog
by Maharathi Basu
ACHR advances with airport acquisitions, global deals and tech partnerships as competition with JOBY intensifies.
NVDAPositive Net Change JOBYNegative Net Change ACHRNegative Net Change
aerospace airlines
FAF Stock Trading at a Discount to Industry at 1.2X: Time to Buy?
Analyst Blog
by Zacks Equity Research
First American is set to gain from investments in technology, expanding valuation and data businesses and effective capital deployment.
RNRNegative Net Change AXSNegative Net Change FAFNo Net Change NMIHPositive Net Change
insurance
3 Wireless Stocks Likely to Thrive Against Industry Shortcomings
Industry Outlook
by Supriyo Bose
CCOI, ATNI and CMBM are set to ride long-term gains from 5G momentum and rising demand for wireless connectivity despite near-term headwinds.
CCOINegative Net Change ATNINegative Net Change CMBMNegative Net Change
communications iot mobile tech-stocks
The Zacks Analyst Blog Highlights Walmart, Intuitive Surgical, Lam Research and BV Financial
Press Releases
by Zacks Equity Research
WMT gains on omnichannel strength and rising e-commerce momentum, though tariffs and expense pressures temper the retailer's outlook.
WMTNegative Net Change ISRGPositive Net Change LRCXPositive Net Change BVFLNegative Net Change
retail